READING INDUCTOR AND THERAPEUTIC AGENT FOR GENETIC DISEASES, CAUSED BY MUTATIONS OF NONSENSE-MUTATION TYPE

摘要

FIELD: chemistry.SUBSTANCE: claimed is group of the inventions, relates to application of compound of structural formula(arbecacin)as reading inductor for induction of reading of premature stop-codon, formed as a result of nonsense-mutations, and to medication, including said inductor, for treatment of genetic disease, caused by nonsense-mutations (for instance, Duchenne muscular dystrophy).EFFECT: realisation of the claimed purpose.4 cl, 10 dwg, 4 tbl